| Name | Title | Contact Details |
|---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Founded in 2009, Nashville-based Applied Health Analytics, LLC provides software and consulting services to health systems interested in supporting primary care strategies, growing revenue, improving reimbursement quality and creating population-health management initiatives. A joint-venture partner with Vanderbilt University Medical Center`s Dayani Center for Health and Wellness, Applied Health Analytics advances the role of hospitals and health systems as they engage employers to enhance individual health and increase share among commercial populations.
Cephalon, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Malvern, PA. To find more information about Cephalon, Inc., please visit www.cephalon.com
Advanced Products Inc is a Conway, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.